Takaaki Tokito

Kurume, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.

Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.

Journal: European thyroid journal

Published: November 26, 2025

Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting.

Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 31, 2025

A Case of Immunotherapy Response to BRAFV600E-Mutant Lung Adenocarcinoma With Initial Resistance to Dabrafenib and Trametinib Combination Therapy.

A Case of Immunotherapy Response to BRAFV600E-Mutant Lung Adenocarcinoma With Initial Resistance to Dabrafenib and Trametinib Combination Therapy.

Journal: Cancer reports (Hoboken, N.J.)

Published: September 05, 2025

Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.

Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.

Journal: European thyroid journal

Published: July 13, 2025

Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab.

Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab.

Journal: Translational lung cancer research

Published: May 13, 2025

Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer.

Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 30, 2025

Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 16, 2025

Phase II study of carboplatin + weekly paclitaxel for advanced lung squamous cell carcinoma with idiopathic interstitial pneumonia (Hanshin Cancer Group IP001).

Phase II study of carboplatin + weekly paclitaxel for advanced lung squamous cell carcinoma with idiopathic interstitial pneumonia (Hanshin Cancer Group IP001).

Journal: Medical oncology (Northwood, London, England)

Published: March 18, 2025

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.

Journal: ESMO open

Published: March 01, 2025

Two Japanese Cases of Breast Cancer That Developed Pembrolizumab-Induced Adrenal Insufficiency and Literature Review.

Two Japanese Cases of Breast Cancer That Developed Pembrolizumab-Induced Adrenal Insufficiency and Literature Review.

Journal: Cureus

Published: February 06, 2025

Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.

Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.

Journal: Gland surgery

Published: January 30, 2025

Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.

Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.

Journal: Annals of surgical oncology

Published: January 06, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026